←Back to Expert Scholars
Translational Medicine / 转化医学Neoadjuvant Immunotherapy, NADIM Trials
Mariano Provencio
MD, PhD
🏢Hospital Universitario Puerta de Hierro🌐Spain
Head, Medical Oncology Department
55
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Mariano Provencio leads the NADIM and NADIM II studies of neoadjuvant chemoimmunotherapy in resectable NSCLC. These trials provided early evidence of dramatic pathologic response rates with combination therapy. He chairs the Spanish Lung Cancer Group and drives European perioperative trial design.
Share:
🧪Research Fields 研究领域
NADIM
NADIM II
neoadjuvant chemoimmunotherapy
NSCLC
Spanish Lung Cancer Group
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Mariano Provencio 的研究动态
Follow Mariano Provencio's research updates
留下邮箱，当我们发布与 Mariano Provencio（Hospital Universitario Puerta de Hierro）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment